We are thrilled to announce that Anchor has successfully raised $30 million in our latest funding round, led by renowned investors including Rapyd Ventures, Entrée Capital, and Tal Ventures, alongside a collection of accomplished CEOs and founders from the tech and finance sectors. Founded in 2021, Anchor is revolutionizing the way businesses handle their billing, collections, and payments through our innovative autonomous billing solution. Our cloud-based platform is designed for the B2B service industry, providing an end-to-end automation experience that eliminates tedious manual tasks, reduces the risks of fraud, and mitigates human error in financial transactions. This significant infusion of capital will enable us to expand our Research and Development efforts at our center in Israel, bolster our product offerings, and enhance our technology to support the evolving billing needs of our clients. Our mission remains clear: we aim to empower business owners to thrive by taking their focus off intricate billing processes and allowing them to dedicate their resources towards what they do best—running their businesses. This funding will bolster our capabilities to continuously innovate and ensure that our clients enjoy a seamless billing experience. We invite businesses looking to simplify their payment processes to visit www.sayanchor.com to learn more and embark on their journey to effortless billing. Together, let’s redefine the way payments are made in the B2B landscape.

Anchor Secures $30 Million in Series A Funding to Revolutionize B2B Billing and Payments
Get the full Anchor company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
BioStem Technologies
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.
$2.5M Unknown
today

Edify Systems
When you're running 10+ stores, the cracks in your operations become expensive. Inconsistent stock levels across sites, manual processes that don't scale, food waste that eats into margins, and zero real time visibility for the ops team. That's what Edify solves. Our AI powered platform gives operations leaders a single system to manage inventory, plan production, and report across their entire estate, whether that's 20 locations or 500. Built in intelligence surfaces the insights that matter, so your team spends less time in spreadsheets and more time running operations. What we cover: Inventory management across all sites. AI driven production planning and prep workflows. Operational reporting and real time visibility. Multi location scalability built in from day one. We work with QSR brands and multi site coffee chains who have outgrown spreadsheets and fragmented systems but need something purpose built for high volume, multi unit operations. If your back of house is holding back your growth, we should talk.
$4.0M Seed
today

Generalist
Generalist is an AI robotics company building general intelligence for the physical world. The founding team includes engineers from OpenAI, Google DeepMind, and Boston Dynamics. The company embraces both large-scale AI and robotics as core to its DNA.
$400.0M Unknown
today

Scotch
From neighborhood stores to destination warehouses, liquor retailers of all sizes have been held back by manual tasks, slow systems and limited business intelligence. So we decided to build something better — smarter software that saves time and improves margins so independent retailers could focus on their customers, not manually managing inventory.
$20.0M Series a
today

Kempfer / K Creative Office
Based in São Paulo, we specialize in social media creation and content, delivering creative solutions that connect, engage, and inspire Com sede em São Paulo, somos especialistas em criação e conteúdo para social media, entregando soluções criativas que conectam, envolvem e inspiram.
$1.3M Unknown
today
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Scotch United States | Series a | $20.0M | today |
| 2 | ![]() vorteX-io France | Series a | $9.2M | today |
| 3 | ![]() Scispot Canada | Series a | $8.0M | today |
| 4 | ![]() Lassie United States | Series a | $47.0M | today |
| 5 | ![]() Terra AI United States | Series a | $20.0M | today |



